Detection of BRCA1/2 Mutations in Circulating Tumor DNA From Patients With Ovarian Cancer | Ratajska | Oncotarget

Oncotarget - United States
doi 10.18632/oncotarget.20722
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Circulating Tumor DNA Detection in Lung Cancer Patients Before and After Surgery

Scientific Reports
Multidisciplinary
2016English

Frequency of BRCA1 Mutations in B&H Breast and Ovarian Cancer Patients

Genetics & Applications
2018English

Clinical Implications of Circulating Tumor DNA From Ascites and Serial Plasma in Ovarian Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Founder BRCA1/2 Mutations Among Male Patients With Breast Cancer in Israel

American Journal of Human Genetics
Genetics
1999English

Circulating Cell-Free DNA and Circulating Tumor Cells, the “Liquid Biopsies” in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2017English

Utility of Circulating Tumor DNA in Cancer Diagnostics With Emphasis on Early Detection

BMC Medicine
Medicine
2018English

HER2 Genomic Amplification in Circulating Tumor DNA From Patients With Cetuximab-Resistant Colorectal Cancer

Oncotarget
Oncology
2015English

Biallelic Deleterious BRCA1 Mutations in a Woman With Early-Onset Ovarian Cancer

Cancer Discovery
Oncology
2012English

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy